Live Breaking News & Updates on Thomas Krivak|Page 1

Stay updated with breaking news from Thomas krivak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Leveraging HRD Testing Results in Ovarian Cancer: Clinical Data

Discussion centered around data from the PAOLA-1 trial, highlighting the prevalence of BRCA1/2 mutations and HRD status in ovarian cancer, and how patients with these alterations may benefit from PARP inhibitor treatment. ....

Thomas Krivak , Thomas Herzog , Ovarian Cancer , Homologous Recombination Deficiency , Hrd Testing , Oc Treatment , Hoc Outcomes , Hrr Pathway , Homologous Recombination Repair ,

Opening Remarks from Dr. Herzog, Dr. Krivak, and Dr. Hagemann

Thomas Herzog, MD, Thomas Krivak, MD, and Ian Hagemann, MD, PhD open their discussion by introducing themselves and the objectives of the program. ....

Thomas Herzog , Kian Hagemann , Thomas Krivak , Optimizing Homologous Recombination Deficiency , Testing Paradigms , Ovarian Cancer ,